Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Post-restructuring, Pfizer R&D focused on its top blockbuster prospects
Post-restructuring, Pfizer R&D focused on its top blockbuster prospects
Post-restructuring, Pfizer R&D focused on its top blockbuster prospects
Submitted by
admin
on October 8, 2013 - 9:43am
Source:
Fierce Biotech
News Tags:
R&D
Pfizer
Headline:
Post-restructuring, Pfizer R&D focused on its top blockbuster prospects
Do Not Allow Advertisers to Use My Personal information
